{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:03:41Z","timestamp":1778724221464,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.08.009","type":"journal-article","created":{"date-parts":[[2007,8,27]],"date-time":"2007-08-27T14:57:05Z","timestamp":1188226625000},"page":"7674-7686","source":"Crossref","is-referenced-by-count":66,"title":["Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs"],"prefix":"10.1016","volume":"25","author":[{"given":"Rodolfo Cordeiro","family":"Giunchetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Corr\u00eaa-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Mendes","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Dian","family":"de Oliveira Aguiar-Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Vitoriano","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e1dia","family":"das Dores Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Cosme Cotta","family":"Malaquias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Lisboa","family":"Mota e Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"de Lana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.08.009_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2007.08.009_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4269\/ajtmh.1990.42.118","article-title":"Canine visceral leishmaniasis in northeast Brazil: assessment of serodiagnostic methods","volume":"42","author":"Evans","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.08.009_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.08.009_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/S0037-86821998000500001","volume":"31","author":"Braga","year":"1998","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.vaccine.2007.08.009_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-4017(02)00351-5","article-title":"Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State, Brazil","volume":"111","author":"Franca-Silva","year":"2003","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4269\/ajtmh.2001.65.510","article-title":"Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil","volume":"65","author":"Palatnik-de-Sousa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.009_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00034983.1995.11813015","article-title":"Experimental models for leishmaniasis and for testing anti-leishmanial vaccines","volume":"89","author":"Hommel","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib8","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.157.11.5034","article-title":"Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis","volume":"157","author":"Webb","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib9","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/IAI.63.5.2062-2069.1995","article-title":"A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice","volume":"63","author":"Wilson","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.08.009_bib10","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","article-title":"Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family","volume":"66","author":"Webb","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.08.009_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0264-410X(00)00207-3","article-title":"Immunization with recombinant LD1 antigens protects against experimental leishmaniasis","volume":"19","author":"Dole","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.009_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1568008023340631","article-title":"Vaccination against Leishmania infections","volume":"2","author":"Mauel","year":"2002","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"10.1016\/j.vaccine.2007.08.009_bib13","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and non-human primate models of the human disease","volume":"69","author":"Campos-Neto","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.08.009_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/14760584.2.5.705","article-title":"Vaccines in leishmaniasis: advances in the last five years","volume":"2","author":"Brodskyn","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.08.009_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-4017(01)00486-1","article-title":"An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine","volume":"100","author":"Gradoni","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-3024.1989.tb00676.x","article-title":"Vaccination trial against canine visceral leishmaniasis. Phocean Veterinary Study Group on Visceral Leishmaniasis","volume":"11","author":"Dunan","year":"1989","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0035-9203(88)90140-X","article-title":"Vaccination and treatment trials against murine leishmaniasis with semi-purified Leishmania antigens","volume":"82","author":"Monjour","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.08.009_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.009_bib19","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.009_bib20","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.009_bib21","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.009_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/infdis\/172.4.1055","article-title":"Identification of Leishmania chagasi antigens recognized by human lymphocytes","volume":"172","author":"Jeronimo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.08.009_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/1566524043360212","article-title":"Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis","volume":"4","author":"Ravindran","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2007.08.009_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0074-02761996000600006","article-title":"Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs","volume":"91","author":"Mayrink","year":"1996","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2007.08.009_bib25","first-page":"441","article-title":"Immune responses in dogs vaccinated with autoclaved Leishmania major promastigotes","volume":"30","author":"Lasri","year":"1999","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2007.08.009_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0147-9571(00)00026-6","article-title":"Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes","volume":"24","author":"Panaro","year":"2001","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2007.08.009_bib27","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2004.03.058","article-title":"Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran","volume":"22","author":"Mohebali","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.009_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.08.009_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.rvsc.2005.09.011","article-title":"Parasite density and impaired biochemical\/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis","volume":"81","author":"Reis","year":"2006","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2007.08.009_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetimm.2006.02.001","article-title":"Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi","volume":"112","author":"Reis","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.vetimm.2004.08.014","article-title":"Establishment of a microplate assay for flow cytometric assessment and it is use for the evaluation of age-related phenotypic changes in canine whole blood leukocytes","volume":"103","author":"Reis","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]-nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2007.08.009_bib33","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/clinchem\/38.10.2152","article-title":"Simple, rapid method for determining nitrates and nitrites in biological fluids","volume":"38","author":"Gutman","year":"1992","journal-title":"Clin Chem"},{"key":"10.1016\/j.vaccine.2007.08.009_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/030098588402100113","article-title":"Visceral leishmaniasis in the German shepherd dog. I. Infection, clinical disease, and clinical pathology","volume":"21","author":"Keenan","year":"1984","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcpa.2006.06.005","article-title":"Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci","volume":"135","author":"Giunchetti","year":"2006","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vetimm.2006.10.001","article-title":"Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi","volume":"115","author":"Lage","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2006.03206.x","article-title":"Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi","volume":"146","author":"Reis","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","article-title":"Chemotherapy of canine leishmaniasis","volume":"106","author":"Baneth","year":"2002","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-3164.2005.00460.x","article-title":"Treatment of canine Old World visceral leishmaniasis: a systematic review","volume":"16","author":"Noli","year":"2005","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-3024.1991.tb00550.x","article-title":"An experimental model for canine visceral leishmaniasis","volume":"13","author":"Abranches","year":"1991","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbieri","year":"2006","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib42","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1172\/JCI112209","article-title":"Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis","volume":"76","author":"Carvalho","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2007.08.009_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2249.2006.03171.x","volume":"146","author":"Peruhype-Magalhaes","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","article-title":"Adjuvant effects of saponins on animal immune responses","volume":"8","author":"Rajput","year":"2007","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.vaccine.2007.08.009_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.009_bib46","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","article-title":"Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil","volume":"25","author":"Parra","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.009_bib47","first-page":"1","article-title":"Saponins as vaccine adjuvants","volume":"13","author":"Kensil","year":"1996","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.vaccine.2007.08.009_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","article-title":"Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis","volume":"36","author":"Fujiwara","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2007.08.009_bib49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","article-title":"Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites","volume":"17","author":"Deplazes","year":"1995","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(97)00072-X","article-title":"Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs","volume":"59","author":"Bourdoiseau","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib51","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.08.009_bib52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vetpar.2007.03.037","article-title":"Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation","volume":"147","author":"Day","year":"2007","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib53","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/intimm\/3.6.587","article-title":"Establishment of resistance to Leishmania major infection in susceptible BALB\/c mice requires parasite-specific CD8+ T cells","volume":"3","author":"Muller","year":"1991","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/IAI.66.1.18-27.1998","article-title":"Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani","volume":"66","author":"Melby","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.08.009_bib55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.23.021704.115825","article-title":"Cooperation between CD4+ and CD8+ T cells: when, where, and how","volume":"24","author":"Castellino","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2007.08.009_bib56","series-title":"Cytokines in veterinary medicine","first-page":"217","article-title":"Cytokines in canine visceral leishmaniasis","author":"Pinelli","year":"1997"},{"key":"10.1016\/j.vaccine.2007.08.009_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1399-0039.1994.tb02315.x","article-title":"Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW)","volume":"43","author":"Cobbold","year":"1994","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2007.08.009_bib58","first-page":"923","article-title":"Modulation by canine interferon-gamma of major histocompatibility complex and tumor-associated antigen expression in canine mammary tumor and melanoma cell lines","volume":"15","author":"Whitley","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/j.vaccine.2007.08.009_bib59","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1089\/104303403322611773","article-title":"Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure","volume":"14","author":"Radosevich","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2007.08.009_bib60","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J Med Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T22:49:44Z","timestamp":1684018184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":60,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07009255"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}